lemborexant tablets

Product Name: Dayvigo 5 mg Tablets Generic Name: Lemborexant Brand: Dayvigo Manufacturer/Brand Owner: Eisai Product Category: Prescription Sleep Disorder Medication Product Description Dayvigo 5 mg contains Lemborexant, a dual orexin receptor antagonist prescribed for the treatment of insomnia in adults who experience difficulty falling asleep or staying asleep. BizHQ, through Medicine India Export, welcomes international sourcing enquiries from licensed pharmaceutical importers, wholesalers, distributors, and healthcare procurement organizations. All product enquiries are subject to verified stock availability, applicable pharmaceutical regulations, and destination-country import authorization. Product Specifications Specification Details Brand Name Dayvigo Active Ingredient Lemborexant Strength 5 mg Dosage Form Film-coated Tablets Therapeutic Category Insomnia Treatment Drug Classification Dual Orexin Receptor Antagonist Pack Size 2 × 14 Tablets (pictured pack) Route of Administration Oral Prescription Requirement Prescription Only Storage Follow approved product labeling Wholesale Availability On Enquiry Minimum Order Quantity Subject to Confirmation Export Eligibility Subject to Applicable Laws Product Uses Dayvigo 5 mg is indicated for treating insomnia in adults, including difficulties with sleep onset and sleep maintenance. It works by blocking orexin receptors involved in maintaining wakefulness. Safety Information: Dayvigo may cause daytime sleepiness, impaired alertness, and other adverse reactions. It must be used according to approved prescribing information and under medical supervision. International Pharmaceutical Trade Enquiries BizHQ accepts enquiries from licensed pharmaceutical businesses in international markets, including: North America: USA, Canada, Mexico Europe: UK, Germany, France, Italy, Spain, Netherlands, Switzerland, Belgium Middle East: UAE, Saudi Arabia, Qatar, Kuwait, Oman, Bahrain Asia-Pacific: Australia, New Zealand, Singapore, Malaysia, Thailand, Philippines Africa: South Africa, Nigeria, Kenya, Ghana, Uganda, Tanzania Latin America: Brazil, Chile, Colombia, Peru, Argentina Countries listed are potential enquiry markets only. They do not represent confirmed product approvals, availability, or authorization to export or import Dayvigo. Packaging and Quality Information Original manufacturer packaging must be verified. Batch number and expiry date should be confirmed before procurement. Product authenticity and traceability documentation should be reviewed. Storage and transportation must follow approved requirements. Import permits and additional controlled-medicine authorizations may be necessary. International Trading FAQs Q1. Is Dayvigo 5 mg available for wholesale supply? Availability and order quantities require confirmation through an appropriately licensed supplier. Q2. Can Dayvigo 5 mg be exported internationally? Only where the proposed export and import are lawful and all relevant pharmaceutical and controlled-substance requirements have been met. Q3. What is the packaging size? The pictured Dayvigo 5 mg carton contains 2 × 14 tablets. Q4. What is the minimum order quantity? MOQ is confirmed individually according to product availability and regulatory requirements. Q5. What documentation is required for international imports? Requirements may include commercial invoices, packing lists, applicable licenses, import permits, product authorization, and batch documentation. Q6. Can licensed distributors request a quotation from BizHQ? Yes. Licensed businesses can submit enquiries for availability and compliance review. Contact BizHQ – Pharmaceutical Product Enquiries Company: BizHQ Website: https://www.medicineindiaexport.com/ Email: sales.medindiaexport@gmail.com WhatsApp: +91 7218129896